WT
KYMR icon

Whittier Trust’s Kymera Therapeutics KYMR Stock Holding History

Whittier Trust’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21K Hold
183
– – ﹤0.01% 1021
2026
Q1 		$15.6K Hold
183
– – ﹤0.01% 1052
2025
Q4 		$13.4K Hold
183
– – ﹤0.01% 1094
2025
Q3 		$10.6K Buy
+183
New +$8.25K ﹤0.01% 1112
2021
Q2 		– Sell
-1,000
Closed -$39K – 1542
2021
Q1 		$39K Hold
1,000
– – ﹤0.01% 990
2020
Q4 		$62K Hold
1,000
– – ﹤0.01% 808
2020
Q3 		$32K Buy
+1,000
New +$30.5K ﹤0.01% 915

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Whittier Trust's KYMR Position: Q2 2026 in Review

Whittier Trust held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 183 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #1021.

Whittier Trust first reported a position in KYMR in Q3 2020 and has held it in 7 quarters since. The position peaked at $62K in Q4 2020. 277 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Whittier Trust held 183 shares of Kymera Therapeutics worth $21K as of Q2 2026.
  • Whittier Trust left its Kymera Therapeutics share count unchanged in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #1021 holding.
  • Whittier Trust first reported a position in Kymera Therapeutics in Q3 2020 and has held it in 7 quarters since.
  • Whittier Trust's Kymera Therapeutics position peaked at $62K in Q4 2020.
  • 277 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.